Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Celgene Corporation    CELG

CELGENE CORPORATION (CELG)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Sector news Pharmaceuticals - NEC
09:09p Wall Street falls as investors fret about tax bill passage
08:31p Perrigo lines up bid for Merck's consumer health unit - sources
04:44p TEVA PHARMACEUTICAL INDUSTRIES : Pharm to lay off a quarter of workforce, suspen..
03:11pDJTEVA PHARMACEUTICAL INDUSTRIES : to Cut 14,000 Jobs, Suspend Dividend -- Update
02:01pDJTEVA PHARMACEUTICAL INDUSTRIES : to Cut 14,000 Jobs
11:42aDJGLAXOSMITHKLINE : GSK Applies for Australian Approval of Malaria Treatment
12/13 TEVA PHARMACEUTICAL INDUSTRIES : Fears of Israeli job cuts at Teva sparks call f..
12/13 France's Sanofi pins hopes on new drugs after setbacks
12/13DJELI LILLY AND : Sees Modest Revenue Growth in 2018
12/13 SANOFI : CEO says M&A targets in oncology are 'very expensive'
12/13DJPLANT IMPACT : Needs Extra GBP7 Million Funding by April, Hands up 'For Sale' Si..
12/13DJSANOFI : to Begin at Least 10 Phase 3 Studies Over Next 12 Months
12/13 SANOFI : Did Sanofi, WHO ignore warning signals on dengue vaccine?
12/12 Sanofi investors hungry for drug progress and deal news
12/12DJMERCK : Appoints Allan Gabor as Managing Director in China
12/12DJGLAXOSMITHKLINE : Encouraged By Blood-Cancer Drug Study
12/12DJSANOFI : Receives U.S. FDA Approval for Insulin Injection Admelog
12/12DJGLAXOSMITHKLINE : Nucala gets FDA Approval for EGPA
12/12 Monsanto offers cash to U.S. farmers who use controversial chemical
12/11 ASTRAZENECA : GSK's new pharma head on lookout for cancer deals to boost pipelin..
12/11DJSANOFI : Urges Philippines to Lift Dengue Vaccine Suspension -AFP
12/11 Merck raises stakes in lung cancer as rivals close in
12/11DJROCHE : Reports Positive Results From IMmotion151 Kidney Cancer Trial
12/11 ROCHE : Tecentriq cocktail slows kidney cancer progression
12/08 EU regulators to warn Bayer about Monsanto bid
12/08 ALEXION PHARMACEUTICALS : Elliott Management seeks changes at Alexion - NYT
12/08 Wall Street closes higher after payrolls report
12/08 TEVA CONSIDERING CUTTING UP TO 10,00 : Bloomberg
12/08 TEVA CONSIDERING CUTTING UP TO 10,00 : Bloomberg
12/08DJSHIRE : Names John Miller as Interim CFO From Jan. 1
12/08DJTEVA PHARMACEUTICAL INDUSTRIES : May Cut Up to 10,000 Jobs -Bloomberg
12/08DJSHIRE PLC SHIRE PLC : Directorate Change
12/08DJROCHE : Novartis's Italian Heads Risk Trial for Alleged Market Rigging -Reuters
12/08 ROCHE, NOVARTIS' ITALIAN HEADS RISK : sources
12/08DJSANOFI : Signs Agreement to Produce Vaccines in Algeria
12/08 SANOFI : Philippines to seek refund of $59 million from Sanofi amid vaccine risk
12/07 TSX gains in broad rally led by financials, energy stocks
12/07 Comeback in banks, tech lifts euro zone stocks as Steinhoff collapses
12/07 Roche drug cocktail doubles chance of holding lung cancer at bay
12/07 Whitbread jumps after hedge fund Sachem Head declares stake
12/07 Companies prepare for disorderly Brexit as talks stall
12/07DJROCHE : Posts Positive Phase 3 Interim Results in Hemophilia Study
12/07DJROCHE : Reports Positive Results From IMpower150 Lung Cancer Trial
12/07DJROCHE : Immunotherapy Drug Tecentriq Extended Patients' Lives in Study
12/06 Roche to seize leap-frog opportunity in lung cancer
12/06DJROCHE : Avastin Granted Full Approval by FDA to Treat Glioblastoma
12/06 GSK, other drugmakers bet on post-Brexit UK science
12/06DJBAYER : Johnson & Johnson Ordered to Pay $27.8 Million in Xarelto Lawsuit -Reute..
12/06DJCREDIT MARKETS : Tax Bill Benefits Corporate Bonds -- WSJ
12/06 Australian watchdog takes GlaxoSmithKline, Novartis units to court
Financials ($)
Sales 2017 12 967 M
EBIT 2017 7 286 M
Net income 2017 4 215 M
Debt 2017 4 463 M
Yield 2017 -
P/E ratio 2017 20,56
P/E ratio 2018 15,25
EV / Sales 2017 6,91x
EV / Sales 2018 5,71x
Capitalization 85 188 M
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
CELGENE CORPORATION-8.35%85 188
JOHNSON & JOHNSON21.53%383 877
NOVARTIS12.01%221 304
PFIZER10.04%218 400
ROCHE HOLDING LTD.3.40%210 833
MERCK AND COMPANY-6.96%155 214
AMGEN19.97%128 762
SANOFI-4.32%111 499
NOVO NORDISK A/S29.49%105 152
BAYER5.62%104 029
BRISTOL-MYERS SQUIBB COMPANY6.81%103 881
ELI LILLY AND COMPANY17.54%96 775
ABBOTT LABORATORIES42.38%95 837
GLAXOSMITHKLINE-17.57%86 798
ASTRAZENECA9.90%83 019
ALLERGAN PLC-20.10%56 286
SHIRE-20.69%44 539
TAKEDA PHARMACEUTICAL CO LTD28.44%43 206
JIANGSU HENGRUI MEDICINE CO LTD43.69%29 600
CHUGAI PHARMACEUTICAL CO LTD74.66%29 108
ASTELLAS PHARMA INC-11.13%26 531